The G allele of SNP E1/A118G at the mu-opioid receptor gene locus shows genomic evidence of recent positive selection.
about
Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans.A genetic determinant of the striatal dopamine response to alcohol in menPharmacogenetic approaches to the treatment of alcohol addiction.Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?
P2860
The G allele of SNP E1/A118G at the mu-opioid receptor gene locus shows genomic evidence of recent positive selection.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The G allele of SNP E1/A118G a ...... of recent positive selection.
@en
The G allele of SNP E1/A118G a ...... of recent positive selection.
@nl
type
label
The G allele of SNP E1/A118G a ...... of recent positive selection.
@en
The G allele of SNP E1/A118G a ...... of recent positive selection.
@nl
prefLabel
The G allele of SNP E1/A118G a ...... of recent positive selection.
@en
The G allele of SNP E1/A118G a ...... of recent positive selection.
@nl
P2093
P2860
P356
P1433
P1476
The G allele of SNP E1/A118G a ...... of recent positive selection.
@en
P2093
Caroline G L Lee
Cynthia Goh
Grace S Y Pang
Jingbo Wang
Zihua Wang
P2860
P304
P356
10.2217/PGS.09.63
P577
2009-07-01T00:00:00Z